- Home
- ROIV vs PAA Comparison
ROIV vs PAA Comparison
Compare ROIV & PAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ROIV | PAA |
|---|---|---|
| Founded | 2014 | 1981 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Natural Gas Distribution |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 12.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ROIV | PAA |
|---|---|---|
| Price | $21.70 | $17.92 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 11 |
| Target Price | ★ $21.94 | $20.40 |
| AVG Volume (30 Days) | ★ 6.7M | 2.6M |
| Earning Date | 11-10-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 8.56% |
| EPS Growth | N/A | ★ 8.03 |
| EPS | N/A | ★ 1.21 |
| Revenue | $20,329,000.00 | ★ $46,917,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $376.94 | $3.43 |
| P/E Ratio | ★ N/A | $14.63 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $15.58 |
| 52 Week High | $22.45 | $21.00 |
Technical Indicators
Market Signals| Indicator | ROIV | PAA |
|---|---|---|
| Relative Strength Index (RSI) | 62.44 | 67.57 |
| Support Level | $20.14 | $17.33 |
| Resistance Level | $21.48 | $17.84 |
| Average True Range (ATR) | 0.71 | 0.26 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 65.96 | 96.81 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About PAA Plains All American Pipeline L.P.
Plains All American Pipeline LP through its subsidiaries, engages in the pipeline transportation, terminaling, storage, and gathering of crude oil and natural gas liquids (NGL) in the United States and Canada. The company operates through two segments, Crude Oil and NGL. The Crude Oil segment offers gathering and transporting crude oil through pipelines, gathering systems, trucks, and barges or railcars. The NGL segment is involved in natural gas processing and NGL fractionation, storage, transportation, and terminalling. It generates the majority of its revenue from the Crude Oil segment.